TG Therapeutics Investigational Trial Site — Huntsville, Alabama

TG Therapeutics Investigational Trial Site is a clinical research site located in Huntsville, Alabama, United States 35805.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

TG Therapeutics Investigational Trial Site has participated in 13 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Non-Hodgkins Lymphoma.

Sponsors: TG Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TG Therapeutics Investigational Trial Site?

TG Therapeutics Investigational Trial Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TG Therapeutics Investigational Trial Site conducted?

TG Therapeutics Investigational Trial Site has 13 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Non-Hodgkins Lymphoma.

Is TG Therapeutics Investigational Trial Site accredited by Crixeo Health?

Yes — TG Therapeutics Investigational Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about TG Therapeutics Investigational Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.